Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,600
Closed -$208K 4010
2023
Q4
$208K Buy
+18,600
New +$171K ﹤0.01% 3536

Other funds holding ETNB

GTS Securities's ETNB Position: Q4 2025 in Review

GTS Securities sold out of 89bio (ETNB) in Q4 2025, closing a stake of 12,725 shares — an estimated $187K sold.

GTS Securities first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $187K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • GTS Securities reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • GTS Securities sold 12,725 89bio shares in Q4 2025, an estimated $187K.
  • GTS Securities first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
  • GTS Securities's 89bio position peaked at $187K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.